ArticleFrontiers in medicine2026
Performance comparison of different machine learning models to predict the risk of postcraniotomy nausea and vomiting: a retrospective study.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Machine learning (ML) models were constructed and validated to predict the risk of postoperative nausea and vomiting (PONV) after craniotomy. We compared different algorithms to provide a reliable tool for clinical decision-making. Methods: Data from patients who underwent craniotomy at a tertiary hospital in Zhejiang Province between January 1, 2021 and December 31, 2022 were retrospectively collected as the training set. LASSO (Least Absolute Shrinkage and Selection Operator) regression with 10-fold cross-validation was used to screen for key predictors, and four prediction models were established: Logistic Regression (LR), Random Forest (RF), eXtreme Gradient Boosting (XGBoost), and Light Gradient Boosting Machine (LightGBM). Patients from September 1, 2023 to December 22, 2023 served as the temporal validation set. Evaluation of model performance was based on accuracy, precision, specificity, recall, F1-score, Brier score, and the area under the receiver operating characteristic curve (AUC). Temporal validation was performed to assess the generalization of the models and decision curve analysis (DCA) was applied to evaluate clinical utility. Results: A total of 768 eligible samples were included, and 14 core predictors were screened by LASSO regression. Of the four constructed risk prediction models, temporal validation based on ML algorithms confirmed that LightGBM achieved optimal comprehensive performance with the highest accuracy, recall, F1-score, and AUC, along with lowest Brier score, indicating that this model had significant advantages in discriminative, calibration, and generalization capabilities. The LR model demonstrated stable performance with high specificity but low recall, indicating a certain risk of missed diagnosis, while the performance of the RF model decreased significantly from the training to validation set, suggesting obvious overfitting and limited clinical application value. The XGBoost model achieved moderate performance, but had a relatively higher Brier score, suggesting moderate prediction error. The DCA results showed that LightGBM offered greater and more stable net benefits across a wider range of clinically relevant threshold probabilities, further supporting its clinical utility. Conclusion: LightGBM shows the best overall performance for risk stratification of PONV after craniotomy, and SHAP visualization endows the model with favorable clinical interpretability to facilitate individualized risk prediction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.